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EXPLANATORY MEMORANDUM
Summary
The proposed amendment to Council Directive 76l768tEEC on the approximation of the laws
of the Member States relating to cosmetic products has four key objectives:
To introduce permanently and definitively a prohibition on the performance of
experiments on animals for finished cosmetic products in the territory of Member
States of the European Union.
To amend the prohibition on the marketing of cosmetic products containing
ingredients or combinations of ingredients tested on animal entering into force after
the 30h June 2000 by introducing a prohibition on the performance of experiments
on animals for ingredients and combinations of ingredients and to make mandatory
use of validated alternative methods for the testing of chemicals used in cosmetic
products, as soon as such methods become available. The Commission will
endeavour to obtain the rapid acceptance by the OECD (Organisation for Economic
Co-operation and Development) of alternative methods validated at Community
level. This prohibition will enter into force three years after the implementation of
the Directive by the Member States. However, the date of implementation of this
prohibition should be'postponed for no more than two years if there has been
insufficient progress in developing satisfactory methods to replace animal testing
scientifically validated as offering an equivalent level of protection for the consumer.
To revise the current legislative provisions so as to make them WTO-compliant,
legally and practically enforceable. For reasons,of consistency and legal certainty,
the Commission intends to adopt a Commission Directive postponing the date of
entry into force of the marketing ban to avoid its enforcement while a substantial
modification of the basic directive is pending before the European Parliament and the
Council. At international level the Commission will endeavour to ensure the rnutual
recognition of test data from in vitrolin vivo studies through negotiations with third
countries.
In order to improve the information.provided to the consumer, to allow the use of
claims indicating that animaltesting has not been performed. However, to ensure that
such claims do not mislead the consumer, the Commission. in consultation with the
Member States, will publish guidelines in order to clarify their use.
This explanatory memorandum explains the background to the current legislative situation,
the context of the current proposal and outlines the end result that is the intent of each specific
item.
l. Axnnll rEsrINc IN THE coSMETICS SECToR
1.1. Background and current legal situation
The text of Article4(l)(i) of DirectiveT61T6SIEEC on cosmetic products as amended by
Council Directive 93l35lEEC of 14 June 1993 (referred to as "the sixth amendment")
provided that "Member States shall prohihit the marketing of cosmetic products containing
ingredients or combinations r$'ingreclients tested on aninwls after I Januury I99g in order to
meet the requirements of this Directive,,.
That Anicle also specifiecl that "if' there hu,s bcen insu.llit'ient pr(),14r(s.r itr tlt,r,t,ltryi,14safi$adory methods to replace animul teslitt;4, urul in purticultrr irt tltrt;c tttsa.s wlrcre
alternative methods tf'testii'ng, despite ull reasonuhla entleavours, huvc rui been scientif'icully
validated as offering an equivalent level of' protection.for tht: consunt(tr, takinl4 inte accrxttttOECD trtxicity te,st l4uidelines, the Commi,ssittn :;hitt, by I Jtututtrv 1g97, .subntir drttli
meusures to postpone the duta oJ' implententatittn oJ'this proviskm lor ti suJl'icient perisd and,in any case, for no less thttn wo years, in accortlanc'e with tie procidure lai; down inAnicle 10.".
Despite reasonable endeavours and whilst some progress had been made in the development
of some alternative methocls, in 1997 no_alternaiive testing metrroos rrao ;;; scientifically
validated as offering an equivalent level of protection for thJconsumer. ns tr,e *ain objective
of Directive 76l768tEEC i_s to protect public health, it is vital to carry out tests to assure thesafety for human health of chemicals used i" ;;;il;'"rormutations. A postponement of themarketing ban was put forward by the Commission in accordance with Article4(l)(i).Commission Directive 97ll8t$C, adopted on 17 April 1997, postponed the ban on the
marketing of cosmetic products containing ingreclients or combinations of ingredients testedon animals until 30June 2000. Article 2 of DirectivegTlIS/EC did, howevel, provide for areassessment of the situation.
only three alternative methods have been validated to date, two are available for the
assessment of skin corrosivity and one for the assessment of phototoxicity. r'urtrrermore, theproposed European Parliament and Council directive umending Directive 76l76glEEC has tobe adopted by co-decision procedure, and then will have to b"-trunrpored by Member Statesinto their national law. It will take up to two years before the proposed Directive can beenforced' In the meantime the ban us fores"en by the current Directive will enter into force.Therefore, in accordance with Article4(lxi) of DirectiveT'lTlgllEC and Arricle 2 ofDirective 97lL8tEC, the Commission should adopt a Directive postponing the date of theentry into force of^the marketing ban. This postponement would just aim to cover theforeseeable period of time needed ior this amendment to be adopted ani transposed.
1.2. Objectives and constraints
when considering the issue of animal testing in the cosmetics sector, l.wo chief objecti'es
must be taken into consideration: coRsumer safety and the reduction, and wherever and assoon as possible, the elimination of animal suflbring. These two consiclcrati'ns arc the ovcr-riding factors that must be addressed in legislative m-easures. However, for any measures to beeffective and enforceable it is also necessary to take account of the constralnts arising frorn
compliance with international trade rules, in particular those of the World Trade organisation(\wo).
1.2.1. Consumer safety
The concept of "cosmetic products" covers products for everyday use throughout life. Theseproducts must not be harmful, either immeciiately (for e^u-pi" by causing ailergic reactions)or in the long term (for exampre reading to cancer or birth creiects).
One of the primary responsibilities of both the European Commission and the Member Statesadministrations is that of consumer safety. This iesponsibility is shared and met by the
Ii
European cosmetic industry which is committed to the marketing of safe products. The
responsibilities of manufacturers with regards to safety are defined through the provisions of
Directive 76l768lEEC. Specifically, Article 2 states that the manufacturer or person
responsible for the placing on the market of the product must ensure that the product must not
cause damage to human health when applied under normal or reasonably foreseeable
conditions of use. Furthermore, the provisions of Article 7a require the availability of an
assessment of the safety for human health of the finished product. To assess the safety of a
cosmetic product, the safety of the finished product and of the ingredients used in its
composition must be assessed taking into consideration the general toxicological profile of the
ingredient, its chemical structure and its level of exposure.
Directive 76l768tEEC does not specify the types of tests to be carried out, or the end-points to
be assessed, as these are addressed on a case-by-case basis for each chemical and product.
However, in order to comply with these requirements, it is clear that the use of data from
some animal tests (whether these tests are performed for the product or the ingredient in
question or whether they constitute historical data is immaterial) is necessary.
The Directive also includes a series of lists of prohibited substances, substances subject to
restrictions and requirements and authorised substances. For instance, preservatives, colorants
and UV filters are subject to "positive listing" in Directive 76l768tEEC and can only be used
if they are listed under the appropriate annex. These lists are regularly adapted to technical
progress once the Scientific Committee on Cosmetic Products and Non-Food Products(SCCNFP) has delivered its opinion on the basis of all available scientific data, and in
particular the results of tests which cover the full range of toxic end-points.
For reasons of consumer safety, it is not possible to abandon safety testing, as the appearance
of new substances necessitates testing for new chemical notification purposes under the
provisions of Directive 67/548|EEC. Similarly, the appearance of new data on existing
substances may retult in the requirement for further testing of chemicals currently used in
cosmetic products.
1.2.2. The reduction and elimination of animal suffiring
While consumer safety must be ensured, the reduction of pain inflicted on animals during
tests, of the number of tests and, wherever and as soon as possible, the elimination of animal
suffering is an objective that is common to all parties involved in this issue. This aim
corresponds to ethical requirements regarding respect for life, supported by public opinion
and the expressed wishes of the European Parliament. This aim is also included in Directive
86l609lEEC regarding the protection of animals used for experimental and other scientific
purposesl.
1.2.3. Compliance with international trade rules, in particular those of the WO
The current wording of Article 4(lxi) of Directiv e 76t768lEEC specifies thar the Member
States must prohibit the marketing of cosmetic products containing ingredients tested on
animals after 30 June 2000, whether such products are manufactured in the European Union
or imported from third countries. However, WTO rules forbid any discriminatory measures
between similar products. Article III.4 of the General Agreement on Tariffs and Trade
oJ L 358, 8.12.1986.
(GATT) says that imported products shall be treated no less favourably that like products of
national origin. As the test method does not have any physical eifect on tlie product,
discrimination on this basis could be considered to be contrary to wTO rules, in particular
Article III.4 of the GATT. In this context it is doubtful whether Article XX of rhe GATT 1994
could provide sufficient justification for measures of this nature.
2. PnoposrnDmr:crrvn
This proposal for a European Parliament and Council Directive takes into account thebackground to, the aims of, and the constraints on the current legislative situation. To take
account of the need to comply with international law, the proposed amendment prohibits theperformance of tests on animals on the territory of the Member States for the purpose of
complying with Directive 76l768lEEC, but not the marketing of products which have been
tested on animals. This represents an advancement for animal piotection in the EuropeanUnion. Moreover, the prohibition in its revised form cannot be challenged under WTo rules.Therefore, this prohibition will cover:
finished cosnetic products from the date of implementation of the Directive by theMember States, and
ingredients after publication in the Official Journal of the European Communities of
an alternative method validated, or endorsed as being sgientifically valid, by the
European Centre for the Validation of Alternative Methodr @CVAN,i) and endorsed
as being applicable to cosrnetic products by the Scientific Committee on Cosmetic
Products and Non-Food Products intended for Consumers (SCCNFp). International
acceptance of such methods is no longer required though it is planned that theCommission will make efforts to secure such acceptance within the.OECD and inbilateral negotiations. However, in order to achieve the highest possible degree of
animal protection, some specific action has to be taken in the sector of cosmeticproducts. Therefore, a deadline for the prohibition on the performance of
experiments on animals for ingredients is foreseen three y"u6 after theimplementation of the Directive by the Member States, regardless of *n"tne. un
' alternative method has been validated. However, the date of-implementation of thisprohibition should be postponed for no more than two years if there has beeninsufficient progress in developing satisfactory methods to replace animal testing
scientifically validated as offering an equivaleni level of protection for the consumer.
The key considerations of this proposar are described berow.
2.1" Finished cosmetic products testing
The proposed directive puts forward a prohibition on the performance of tests on animals for
cosmetic finished products within the territory of the lviember States. Given the scientificprogress made to date, the safety of finished products can generally be assessed from existingknowledge on the toxicity of the ingredients and their phyJicochemical properties, along withthe use of methods which do not involve animals. Therefore, a prohibiiion on the testing offinished products in the Community is seen as feasible. ' r
This proposal would solve a problem of interpretation in the current text of Directi'e76/768|EEC as to whether the phrase "ingredienfs or combinations of ingredients,, inclucles
I
finished products and, at the sanre tinp, fulfil the commitrnent entered inlo with the European
Parliament bf tf Commission.
2.2. Cosrneticingredienfstesting
Progress has been made which makes it-possiblc to reducc thc numbcr ol'animals used in
experimentation and reduce the level of suffering involved, in line with the "3Rs" concept of
replacement, reduction and refinement. However, the development, validation and acceptance
of alternative methods have proven to be an extrernely complex scientific challenge. In
particular, the timetable for the various stages of the development and validation process had
previously been underestimated, and progress has not been as rapid as hoped by all parties. It
has not been possible to timetable and schedule the necessary research into complex
biological systems.
This proposal introduces the principle of an immediate and mandatory introduction of
validated alternative rrcthods for testing cosnretic ingredients as soon as they beconp
available.
The current Article 4(l)(i) contains a reference to the OECD and includes the phrase
"altentative methods of testing ... scientifically valicluted us oJJering un equivalent level of
protection for the consumer, taking into accaunt OECD toxicity test guidelines." While the
Commission must make efforts to convince the OECD to accept alternative methods validated
by ECVAM, experience has shown that it has sornctimes takcn several years for an existing
method to be accepted by all OECD membcrs. In this situation, because of the moral
importance of animal welfare it is not possible to wait for such acceptance by the OECD.
Action is needed at Community level given the existence of alternative methods which have
been validated or endorsed as being scientifically valid by ECVAM and endorsed by the
ECVAM Scientific Advisory Committee. Therefore, a new approach is put forward in the
proposed directive, in that regulatory acceptance at a European level will be sufficient to
permit legislative proposals for cosmetic testing in the European Union. Once a method has
been validated or endorsed as being scientifically valid by ECVAM and the SCCNFP and
endorsed by the Commission services, it will be published and accepted for use in the
European Union. Furthermore, use of an animal test that assesses the same toxic end-point
will be prohibited in the European Union. This will be the situation prior to OECD
acceptance, and will be a major advancement in speeding up the regulatory acceptance of
alternative methods.
Further work is required for some of those end-points that are of greatest importance to
human health and to the cosmetic industry i.e. acute effects to the skin and eyes and long term
systemic effects. To this end, research efforts should be intensified. Taking into account the
progress made in the development of alternative methods to date, it can be reasonably
expected that within five to seven years, a battery of in vitro tests could well be available for
testing the possible'short-term toxic effects of a cosnrctic product. Therefore it is proposed to
introduce a definitive prohibition on the performance of tests on animals for cosmetic
ingredients three years after the implementation of the Directive by the Member States.
However, the date of implementation of this prohibition should be postponed for no more
than two years if there has been insufficient progress in developing satisfactory methods to
reptace animal testing scientifically validated as offering an equivalent level of protection for
the consumer. This prohibition, of course, does not apply to testing carried out for the
purposes of meeting other regulatory requirements if the samc chemical ingredient is also
used in other applications (e.g. pharmaceuticals) outside the scope of DirectiveT6lT6S|EEC.
For the long term effects, the prospects of development and. validation of in vitrc methods are
less promising. For those end-points it will bc nccessary tb rcly on thc usc of chernicals ancl
ingredients with established toxicological profilcs or usc new chcmicals which havc bccn
tested to meet regulatory requirements other than this Dircctive.
2.3. European lead in the acceptance of alternative methods and mutual recognition
with third countries
It will be important to continue negotiations within the OECD to ensure a truly global
acceptance of alternative methods to animal testing. The Commission will.continue to work
with the OECD in this respect and will endeavour to gain wider regulatory acceptance at the
earliest opportunity. By taking a lead in the regulatory acceptance of validated alternative
methods, it is hoped that the example set by the European Union will expedite discussions at
the levelof the OECD.
At the same time as continuing discussions with the OECD, the Commission will initiate
bilateral talks on mutual recognition with third countries. Mutual recognition agreements with
third countries are a pivotal element of this new approach and will be essential if the actions
that are proposed at Community level are to lead to a genuine reduction of animals elsewhere.
The aim of these discussions wilt be to ensure the mutual recognition of data generated to
support the safety of products or ingredients. From an European Union point of view, the
Commission will push for the acceptance of data derivcd from in yilro studiis, using validated
alternative methods that have been conducted to fulfil the requirements of Directive
76l768tEEC. Obviously, it is important that third countries do not require the repetition of the
studies using animal models due to the non-acceptance of data from in vitrolalternative
methods. Only by this way will the European Union be able to ensure a benefit to animal
welfare on a more global level, Conversely, the European Union will need to accept data from
studies conducted in animals, that may be used as supporting data for cosmetic
ingredients/products. Such studies would have been conducted to satisfy the legislative
demands of third countries in any case. Mutual recognition is the key to this approach 
- 
it
would be inappropriate for the European llnion to demand the repetition of a teit using an
alternative methods, as this would set up a barricr to trade aird may impact upon any
favourable position taken upon the acceptability of Eunrpean in vitro data. This approach also
obviates the criticism that the new, WTO-compliant lcgislative mcasures on animil testing in
the sectorof cosrnetic products simply "export" the problem. Rather, it is a genuine initiative
to gain regulatory acceptarrce of alte;;ative methods on a gtobal scale.
2.4, Claims on animal tests
To improve the information provided to the consumer, this proposal also foresees the
possibility for the manufacturer or the person responsible for placing the product on the
market to claim that no animal tests have been carried out (directly or indirectly). However to
avoid an abuse of these claims, the Commission, in collaboration with the Member States,
will produce guidelines to define their use. These guidelines will need to include specific
provisions which would require that the finished product and the ingredients have never been
tested on animals, including for purposes outside the scope of this Directive.
The problem of the potential misleading nature of animal testing claims has alrcady been
identified in a number of Member States. Thc currcnt wording ol Articlc 6(3) ol' Dircctivc
76l768tEEC as it relates to animal testing is "liurthcnnorc, uny rrli,rcn<.t, lo t<:stirt33 tttr
animals must state c*learly whether the test is currietl out inwilved the.f'ini.vhetl prrxlut't undfttr
its ingredienrs.". Different national interprctations ol'thc mcaning ol' Articlc (r(3) havc lcad t6
a
a
slg*ificant disruption on the single market. Furthernalre, the varicty of' clairns used by
cornpanies within the European Union, ancl the even greaten variety ol'critcria to support these
claims, have led to confusion in the European marketplace on the part of consumers and
regulators.
The aim of the guidelines proposed is to ensure that common critcria are appliecl in the usc of
ciaims relating to animaltesting, that an aligned unclerstanding of the claimi is rcached ancl in
particular, that such claims do not mislead the consumer.
2,5. The cost to industry
The prohibitian on the performance of experiments on animals will impose additional costs
on industry, in particular on small and medium enterprises, which do not have the specific
databases, knowledge or toxicology specialists to which large companies have access.
If small and medium enterprises use contract laboratories to carry out alternative tests, they
will need to know when to carry out such tests and how to interpret the results. The European
Cosmetic Toiletry and Perfumery Association (COLIPA) has drawn up guidelines for
assessing the safety of cosmetic products which should be useful for small and medium
enterprises. These should be made widely available, in electronic format whenever possible.
3"
3.1.
OrHsn AMENDMENTSTo DrRECTtvn 76n68lWF,C or.r cosrurlrrc pRoDUCTs
Scientific Committee on Cosmetic l'roducts and Non-Fcrcd Products intended
for Consumers
The Comrnission obtains scientific advice on the safety of cosmetic products through
consultation with a scientific committee. Previ:usly referred to as the Scientific Committee
on Cosmetology, the functioning and composition of the Committee was restructured through
the provisions of Commission Decision 9715791F,{. This Decision outlined the requirements
for setting up the Scientific Committee on Cosmetic Products and Non-Food Products
intended for Consumers (SCCNFP) as one of eight new committees. This committee remains
the scientific committee that will advise the Commission on matters related to the safety of
cosmetic products. Therefore, Articles 8(2) and 8a(3) of Directive 761768|EEC should refer to
the Scientific Committee on Cosmetic Products and Non-Food Products intended for
Consumers (SCCNFP).
3.2. Standing Committee on Cosmetic Products
The current Articleg(l) sets up a Committee on the Adaptation to Technical Progress of the
Directives on the Removal of Technical Barriers to Trade in the Cosmetic Products Sector. It
is .proposed that this Committee is renamed as the "Standing Committce on Cosmetic
Products", by analogy with the titles of similar regulatory committees in other sectors.
3.3. Comitology procedure
Following the adoption of Council Decision l999l468lBC of 28 June 1999 laying down the
procedures for the exercise of implementing powers conferred on the Commission, it has
become necessary to adjust the relevant decision-making procedures. In its declaration of 28
June 1999 the Commission agreed that the necessary adjustments to the decision-making
process would be made in the course of the nornval revision of the legislation. Therefore, it is
necessary to amend Article l0 to align the decision-making process.
4. Bupcnranyh{?rlcaTrolrr$ToruuCournsstoN
No budgetary implications to the Commission are foreseen as a result of the provisions of the
proposed Directive.
5. SUBSIDIARITv AND pRopoRTIoNALITy 
i
Community law already provides for an exhaustivc harm<lnisation rcgarding thc placrng on ,
the market of cosmetic products within the European Union, the rcspective rules for which are
based on Article 95 of the Treaty. The only appropriate way of amending these rules is (
therefbre through the provisions set out in Community law.
The proposed measuresr achieve the objectives with minimat intervention regarding regulatory
and admin istrative rcquirements
Proposal for a
DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
amending for the seventh time Council DirectiveT61T6S|EEC on the approximation of
the laws of the Member states relating to cosmetic products
(Text with EIIA relevance)
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Community, and in particular
Article 95 thereof,
Having regard to the proposal from the Commission2,
Having regard to the opinion of the Economic and social committee3,
Acting in accordance with the procedure laicl down in Article 251 ofthc Treaty,
Whereas:
(l) Council Directive 76l768lEEC4, as
Directive zCfJflt lllEc5, has comprehensively
cosmetic products. The main objective of the
this end it is indispensable to carry out certain
of cosmetic products for human health.
last amended by Commission
harmonised the national laws relating to
Directive is to protect public health. To
toxicological tests to evaluate the safety
(2)
(3)
In accordance with Directive 76l768tEEC. it is essential that rhe aim of abolishing
animal experiments be pursued and that the prohibition of such experiments becomes
effective on the tenitory of the Member States.
The safety of finished cosmetic products can already be assessed from knowledge
about the safety of the ingredients which they contain and by methods which do not
involve the use of animals. Therefore animal tests on finished cosmetic products
should be prohibited.
It will progressively but slowly be possible to ensure the safety of thc ingreclients ancl
combinations of ingredients used in cosmetic products, at least for the acute effects,
without recourse to animal experiments, by using alternative methods validated at
Community level, or approved as being scientifically validated, by the European
Centre for the Validation of Alternative Methods (ECVAM). After consulting the
OJC,,p..
OJ C,, p. .
Ol L 262, 27.9.197 6, p. 169.
OJL65, 14.3.2000.,p.22.
(4)
2
3
4
to
(6)
Scientific Committee on Cosmctic Products and Non-Frxrd I'roducts intcndcd lirr
. 
Consumers (SCCNFP) as regards thc applicability ol'thc validatcd altcrnativc methods
to the field of cosmetic products, the Commission will have immcdiatcly to pLrblish the
validated or approved methods recognised as being applicablc to such ingredicnts. ln
ordgr to achieve the highest possible degrbe of animal protection, a deadline has to be
foreseen, when a definitive prohibition should be introduced. Flowever, the date of
implementation of this prohibition should be postponed if there has been insufficient
progress in developing satisfactory methods to replace animal testing scientifically
validated as offering an equivalent level of protection for the consumer.
(5) All efforts must be made to ensure that the ethical requirement of animal welfare is
recognised world-wide. To this end, the Commission should endeavour to obtain the
rapid acceptance by the Organisation for Economic Co-operation and Development
(OECD) of alternative methods validated at Community level. Furthermore, in the
framework of bilateral agreements with third countrics, thc Commission should makc
efforts to obtain recognition of thc rcsults ol'tcsts carrie<l out in thc Community using
alternative methods so as not to obstruct thc cxport of cosmctic pnlducts lirr which
such methods have been used.
It should be possible to claim on a cosmetic product that no experiment on animals
was ever carried out on the finished cosmetic product and/or its ingredients and
combinations of ingredients including for the purposes outside the scope of Directive
76:768{EEC. The Commission, in consultation with the Member States, should
produce guidelines with the aim of providing clarity and practical guidance to the
cosmetic industry, European regulators and above-all the consumer with respect to
claims relating to animal testing within the cosmetic sector. These guidelines should
aim to ensure that common criteria are app.lied in the use of claims and that an aligned
understanding of the claims is reached, and in particular that such claims do not
mislead the consumer.
(7) Since the measures necessary for the implementation of this Directive are measures of
general scope within the meaning of Articlc 2 of Council Dccision l999l468lBC of 28
June 1999 laying down the p-rocedures for the exercise of implementing powers
conferred on the Commission6, they should be adopted by use of the regulatory
procedure provided for in Article 5 of that Decision,
HAVE ADOPTED THIS DIRECTIVE:
Anicle I
Council Directive 76l768tEEC is hereby amended as follows:
l. Article 4(lXi) is deleted.
2. The following Article 4a is added:
"Article 4a
tl
OJ L 184, t7.7.1999. p.23
2.
3.
l. Member States shall take all necessary measures to prohibit the performance
on their territory of animal tests in order to meet the requirements of this
Directive:
(a) for tests performed on finished cosmetic products [from I December
20011;
(b) for tests performed.on ingredients or combinations of ingredients, as
soon as an alternative method has been published by the commission,
after endorsement of its scientific validity by the European Centre for the
Validation of Alternative Methods (ECVAM) and the ECVAM Scientific
Advisory Committee, following consultation of the Scientific Committee
on Cosmetic Products and Non-Food Products intended for Consumers-
and in any case [from I December 2004). However, if there has been
insufficient progress in developing satisfactory methods to replace
animal testing scientifically validated as offering an equivalent level of
protection for the consumer, the commission shall, by [l June zo04],
submit draft measures to postpone the date of implementation of this
provision for a sufficient period, and in any case for no more than two
years, in accordance with the procedure laid down in Article 10.
For the purposes of this Directive, "finished cosmetic product" means the
cosmetic product intended to bc supplied in its existing state to the final
consumer.
The Commission shall present an annual report to the European Parliament and
the Council on progress in the development, validation and legal acceptance of
alternative methods to those involving experiments on animals until the entry
into force of the prohibition referred to in paragraph l(b). Thar repoft shall
contain precise data on the number and type of experiments relating to
cosmetic products carried out on animals. The Member States shall be obliged
to collect that information in addition to collecting statistics as laid down by
Directive 86/609/EEC on the protection of animals used for experimental and
other scientific purposes. The Commission shall pay particular attention to the
development, validation and legal acceptance of experimental methods which
do not use live animals.".
Article 6(3) is amended as follows:
a) The last sentence of Article 6(3) is deleted.
b) The following second subparagraph is added:
"Furthermore, the manufacturer or the person responsible for placing the product on
the Community market may only take advantage, on the product packaging or in any
document, notice, label, ring or collar accompanying or referring to the product, of
the fact that no animal tests have been carried out providecl neither the finished
product, nor its prototype, nor any of the ingredients contained in it have ever been
the subject of such tests including for purposes outside the scope of this Directive.
The Commission, in consultation with the Member States, shall for this purpose
publish guidelines on the implementation of this principle.".
J.
l2
4.
5.
6.
In Article 8(2) and Article 8a(3), thc title "Scientific Cornmittcc on Cosmetology" is
replaced by the trtle "Scientific Committce on Cosmetic Products and Non-Fiood
Products intended for Consumers".
In Article 9(l), the title "Committee on the Adaptation to Tccl"rnical Progress cl'the
Directives on the lRemoval of Technical Barriers to Trade in thic Cosrnetic Prociucts
Suctor" is replaced by the title "Standing Cornmittee on Cosmetic Products".
Article 10 is replaced by the following text:
l.
"Article l0
The Commission shall be assisted by the Committee
Where reference is made to this paragraph, the regulatory procedure laid down
in Article 5 of Decision 19991468/EC shall apply, in compliance with Article
7(3) and Article 8 thereof.
The period provided for in Article 
-5(6) of Decision lgggl468/EC shall be rhree
months.".
Article 2
Member States shall bring into force thc laws, regulations and administrative
provisions necessary to comply with this Directive no later than I December 2001].
They shall forthwith inform the Commission thereof.
When Member States adopt those provisions, they shall contain a reference to this
Directive or shall be accompanied by such referenee at the time of their official
publication. Member States shall determinc how such reference is to be made.
2. Member States shall communicate to the Commission thc provisions of national law
which they adopt in the field covered by this Directive.
Article 3
This Directive shall enter into force on the third day following that of its publication in the
Official Journal of the European Communities.
Articte 4
This Directive is addressed to the Member States.
Done at Brussels.
f
I
2.
3.
L
For the European Parliament
The President
fur lhe Ctruncil
The Pra:;ident
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